These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 31380891)

  • 1. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.
    Douketis JD; Spyropoulos AC; Duncan J; Carrier M; Le Gal G; Tafur AJ; Vanassche T; Verhamme P; Shivakumar S; Gross PL; Lee AYY; Yeo E; Solymoss S; Kassis J; Le Templier G; Kowalski S; Blostein M; Shah V; MacKay E; Wu C; Clark NP; Bates SM; Spencer FA; Arnaoutoglou E; Coppens M; Arnold DM; Caprini JA; Li N; Moffat KA; Syed S; Schulman S
    JAMA Intern Med; 2019 Nov; 179(11):1469-1478. PubMed ID: 31380891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale.
    Douketis JD; Spyropoulos AC; Anderson JM; Arnold DM; Bates SM; Blostein M; Carrier M; Caprini JA; Clark NP; Coppens M; Dentali F; Duncan J; Gross PL; Kassis J; Kowalski S; Lee AY; Le Gal G; Le Templier G; Li N; MacKay E; Shah V; Shivakumar S; Solymoss S; Spencer FA; Syed S; Tafur AJ; Vanassche T; Thiele T; Wu C; Yeo E; Schulman S
    Thromb Haemost; 2017 Dec; 117(12):2415-2424. PubMed ID: 29212129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periprocedural Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy.
    Hansen-Barkun C; Martel M; Douketis J; Abraham NS; Liederman Z; Kaplovitch E; Schulman S; Spyropoulos AC; Majid A; Barkun AN
    Am J Gastroenterol; 2023 May; 118(5):812-819. PubMed ID: 36434811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative Management of Patients Taking Direct Oral Anticoagulants: A Review.
    Douketis JD; Spyropoulos AC
    JAMA; 2024 Sep; 332(10):825-834. PubMed ID: 39133476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study.
    Tafur AJ; Clark NP; Spyropoulos AC; Li N; Kaplovitch E; MacDougall K; Schulman S; Caprini JA; Douketis J
    J Am Heart Assoc; 2020 Oct; 9(19):e017316. PubMed ID: 32969288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Direct Oral Anticoagulant, Patient, and Surgery Characteristics on Clinical Outcomes in the Perioperative Anticoagulation Use for Surgery Evaluation Study.
    MacDougall K; Douketis JD; Li N; Clark NP; Tafur A; D'Astous J; Duncan J; Schulman S; Spyropoulos AC
    TH Open; 2020 Jul; 4(3):e255-e262. PubMed ID: 32984757
    [No Abstract]   [Full Text] [Related]  

  • 7. Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A Population-Based Cohort Study.
    Lau WCY; Cheung CL; Man KKC; Chan EW; Sing CW; Lip GYH; Siu CW; Lam JKY; Lee ACH; Wong ICK
    Ann Intern Med; 2020 Jul; 173(1):1-9. PubMed ID: 32423351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population.
    Amin A; Keshishian A; Trocio J; Dina O; Le H; Rosenblatt L; Liu X; Mardekian J; Zhang Q; Baser O; Vo L
    Curr Med Res Opin; 2017 Sep; 33(9):1595-1604. PubMed ID: 28635338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery.
    Siscos SM; Neill BC; Singh AH; Hocker TLH
    J Am Acad Dermatol; 2021 Feb; 84(2):425-431. PubMed ID: 33045293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study.
    Abraham NS; Noseworthy PA; Yao X; Sangaralingham LR; Shah ND
    Gastroenterology; 2017 Apr; 152(5):1014-1022.e1. PubMed ID: 28043907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 12. A Survey of Direct Oral Anticoagulant Cessation in General Surgery and Outcomes in Patients with Nonvalvular Atrial Fibrillation.
    Kawabata M; Goya M; Maeda S; Yagishita A; Takahashi Y; Sasano T; Hirao K
    Int Heart J; 2020 Sep; 61(5):905-912. PubMed ID: 32921660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study.
    Kjerpeseth LJ; Selmer R; Ariansen I; Karlstad Ø; Ellekjær H; Skovlund E
    PLoS One; 2019; 14(8):e0221500. PubMed ID: 31449560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure.
    Douketis JD; Wang G; Chan N; Eikelboom JW; Syed S; Barty R; Moffat KA; Spencer FA; Blostein M; Schulman S
    J Thromb Haemost; 2016 Jan; 14(1):89-97. PubMed ID: 26512880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.
    Martinez BK; Sood NA; Bunz TJ; Coleman CI
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
    Kuno T; Takagi H; Ando T; Sugiyama T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Briasoulis A; Burger A; Bangalore S
    J Am Coll Cardiol; 2020 Jan; 75(3):273-285. PubMed ID: 31976865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study.
    Staerk L; Gerds TA; Lip GYH; Ozenne B; Bonde AN; Lamberts M; Fosbøl EL; Torp-Pedersen C; Gislason GH; Olesen JB
    J Intern Med; 2018 Jan; 283(1):45-55. PubMed ID: 28861925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study.
    Tapaskar N; Ham SA; Micic D; Sengupta N
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):381-389.e9. PubMed ID: 33227428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation.
    Brais C; Larochelle J; Turgeon MH; Blais L; Farand P; Perreault S; Letemplier G; Beauchesne MF
    J Pharm Pharm Sci; 2017; 20():8-14. PubMed ID: 28459661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.